Previous close | 106.10 |
Open | 105.98 |
Bid | 109.09 x 200 |
Ask | 109.55 x 100 |
Day's range | 105.26 - 109.42 |
52-week range | 78.35 - 109.42 |
Volume | |
Avg. volume | 139,638 |
Market cap | 1.789B |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | 27.18 |
EPS (TTM) | 4.02 |
Earnings date | 01 Aug 2024 - 06 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 113.13 |
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
Addus HomeCare Corporation (NASDAQ:ADUS) Q1 2024 Earnings Call Transcript May 7, 2024 Addus HomeCare Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Addus HomeCare’s First Quarter 2024 Earnings Conference Call. All participants will […]
DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.